London, June 15, 2026, 15:05 BST
- Haleon was down 0.12% at 336.40p in London afternoon trade. Shares traded between 334.70p and 341.90p for the session. Google
- Haleon has cancelled 565,285 shares tied to its 2026 buyback, the most recent filing shows. Investegate
- Investors are eyeing H1 2026 results on July 30. Key points are the pace of sales growth and North America’s numbers. Haleon Corporate
Haleon PLC dipped in London Monday, down 0.12% at 336.40p as of 15:05 BST. The FTSE 100 consumer-health stock kept slipping as investors stay cautious after a rocky start in 2026. Sellers nudged the price down but no fresh earnings news or major headlines. Trading volume was light at 7.14 million shares, according to Google Finance, well below the typical 23.55 million. No sign of heavy selling. Google
Haleon bought back 565,285 ordinary shares for cancellation at an average price of 331.9552p each in its March buyback program. Once the deal settles, the company will have 8.83 billion ordinary shares with voting rights left. Fewer shares in issue can lift EPS if profits hold. Investegate
Haleon has a buyback as part of its broader capital return push. The company set aside £500 million for share buybacks in 2026 and kicked off the programme on the market March 12, aiming for the full amount, according to its investor page. Haleon Corporate Bulls like the consistent cash flow from brands like Sensodyne, Panadol, Advil and Centrum, saying that’s a reason to keep holding. Haleon is still pulling in enough cash to pay for both buybacks and ongoing investment. In a trading update in April, Haleon reported first-quarter revenue of £2.86 billion and 2.2% organic revenue growth. Organic growth strips out currency and portfolio effects to reveal base demand. Haleon Corporate
Haleon missed its own Q1 target for 4% to 6% annual organic revenue growth. Management blamed lower demand for cold and flu items, with Respiratory Health organic revenue off 3.4% and Pain Relief posting a 0.3% decline. North America organic growth came in at 1.0%. That’s slow for such a critical market. CEO Brian McNamara called the quarter “a competitive performance in a challenging market.” He said he sees better growth in the months ahead. Haleon Corporate
Haleon shares trade at a price-to-earnings ratio of 18.21, with a dividend yield of 2.11%, both from Google Finance data. The stock doesn’t look especially cheap, but not stretched either. Analyst calls on Google Finance list 7 buys, 2 holds and 1 sell, putting the average 12-month target at 426.67p, and the lowest at 325p—just under the current price. Execution will be important for any recovery. Google
Haleon will report H1 2026 results on July 30. Investors are watching for organic sales growth, North America numbers beyond price increases, and whether stronger margins from productivity can support both investment and payouts. A beat could make a buyback possible for the shares. But if growth is similar to Q1, the stock’s defensive appeal may lack traction. Haleon Corporate
